"Graft vs Leukemia Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunological rejection of leukemia cells following bone marrow transplantation.
| Descriptor ID |
D020544
|
| MeSH Number(s) |
G12.875.402.320.320
|
| Concept/Terms |
Graft vs Leukemia Effect- Graft vs Leukemia Effect
- Graft-vs-Leukemia Response
- Graft-vs-Leukemia Responses
- Response, Graft-vs-Leukemia
- Responses, Graft-vs-Leukemia
- Graft vs Leukemia Response
- Graft-vs-Leukemia Effect
- Effect, Graft-vs-Leukemia
- Effects, Graft-vs-Leukemia
- Graft-vs-Leukemia Effects
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Leukemia Effect".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Leukemia Effect".
This graph shows the total number of publications written about "Graft vs Leukemia Effect" by people in this website by year, and whether "Graft vs Leukemia Effect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2013 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Leukemia Effect" by people in Profiles.
-
Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants. Chimerism. 2015 Jul 03; 6(3):47-9.
-
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia. Exp Hematol. 2013 Sep; 41(9):772-8.
-
Older patients/older donors: choosing wisely. Hematology Am Soc Hematol Educ Program. 2013; 2013:70-5.
-
Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. Hematology Am Soc Hematol Educ Program. 2013; 2013:56-62.
-
Stem cell transplant as an immunomodulatory tool for children with hematologic malignancies. Am Soc Clin Oncol Educ Book. 2013.
-
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction. Biol Blood Marrow Transplant. 2010 May; 16(5):565-86.
-
Late relapse following allogeneic transplant for chronic lymphocytic leukemia: how good are graft versus leukemia effects? Leuk Lymphoma. 2008 Sep; 49(9):1651-2.
-
Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels. Biol Blood Marrow Transplant. 2008 Mar; 14(3):290-300.
-
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. Biol Blood Marrow Transplant. 2006 Jan; 12(1):1-30.
-
Low-grade lymphoma. Hematology Am Soc Hematol Educ Program. 2004; 203-20.